NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations

NCT06494540 · clinicaltrials.gov ↗

RECRUITING

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-squamous Metastatic Non-Small-Cell Lung Carcinoma

Sponsor

AstraZeneca